Evidence map›Paper›PMID 21276790›Full record

ArticleDevelopmental biology2011

Identification of a dopaminergic enhancer indicates complexity in vertebrate dopamine neuron phenotype specification.

Esther Fujimoto, Tamara J Stevenson, Chi-Bin Chien, Joshua L Bonkowsky

Abstract read
In one paragraph

Article in Developmental biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. CRISPR/Cas9-based QF2 knock-in at theFrontiers in neuroanatomy · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. The conserved dopaminergic diencephalospinal tract mediates vertebrate locomotor development in zebrafish larvae.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Esther FujimotoDivision of Pediatric Neurology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Tamara J Stevenson
Chi-Bin Chien
Joshua L Bonkowsky
University of Utah · US

Funding

University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jun Yang · 2005 to 2026
$14.6M
Genetic /Developmental Mechanisms of Pediatric DiseasesK12HD001410 · NICHD · UNIVERSITY OF UTAH · PI CLARK, EDWARD BOWERSOX · 2003 to 2012
$4.3M
Genetic and imaging tools to visualize neuronal subsets in developing zebrafishR01MH092256 · NIMH · UNIVERSITY OF UTAH · PI DORSKY, RICHARD I · 2010 to 2014
$1.8M
Characterization and Genetic Analysis of Basal Ganglia Axon PathfindingK08DA024753 · NIDA · UNIVERSITY OF UTAH · PI BONKOWSKY, JOSH LEITCH · 2008 to 2013
$931k
NEI NIH HHS P30 EY014800NICHD NIH HHS K12 5HD001410NICHD NIH HHS K12 HD001410NIDA NIH HHS K08 DA024753NIMH NIH HHS R01 MH092256
6 · The paper itself

Abstract

The dopaminergic neurons of the basal ganglia play critical roles in CNS function and human disease, but specification of dopamine neuron phenotype is poorly understood in vertebrates. We performed an in vivo screen in zebrafish to identify dopaminergic neuron enhancers, in order to facilitate studies on the specification of neuronal identity, connectivity, and function in the basal ganglia. Based primarily on identification of conserved non-coding elements, we tested 54 DNA elements from four species (zebrafish, pufferfish, mouse, and rat), that included 21 genes with known or putative roles in dopaminergic neuron specification or function. Most elements failed to drive CNS expression or did not express specifically in dopaminergic neurons. However, we did isolate a discrete enhancer from the otpb gene that drove specific expression in diencephalic dopaminergic neurons, although it did not share sequence conservation with regulatory regions of otpa or other dopamine-specific genes. For the otpb enhancer, regulation of expression in dopamine neurons requires multiple elements spread across a large genomic area. In addition, we compared our in vivo testing with in silico analysis of genomic regions for genes involved in dopamine neuron function, but failed to find conserved regions that functioned as enhancers. We conclude that regulation of dopaminergic neuron phenotype in vertebrates is regulated by dispersed regulatory elements.

Indexed as

Enhancer Elements, GeneticAnimalsAnimals, Genetically ModifiedDopamineGene Expression Regulation, DevelopmentalHomeodomain ProteinsHumansMiceModels, NeurologicalNerve Tissue ProteinsNeurogenesisNeuronsPhenotypeRatsTetraodontiformesZebrafishDopamineHomeodomain ProteinsNerve Tissue Proteins

Identifiers

PMID21276790
PMCPMC3069253
OpenAlexW2039213436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.